PRESENTATION | Deals
Europe’s place on the partnering path
An analysis of deal trends finds Europe’s selling point is its early-stage innovation
July 10, 2021 1:40 AM UTC
European partnerships have been center stage in the global response to the COVID pandemic, putting the region’s innovation squarely on the map for future partners.
The relationship between BioNTech SE (NASDAQ:BNTX) and Pfizer Inc. (NYSE:PFE) was forged in a 2018 deal to create flu vaccines; the deal between AstraZeneca plc (LSE:AZN; NASDAQ:AZN) and Oxford University was created in the cauldron of the pandemic. Both yielded products that have defined the industry’s most important achievement since the birth of biotech...